Seer, Inc.

Impact: Seer, Inc. is the primary complainant in the patent infringement cases, seeking to protect its intellectual property related to nanoparticle protein enrichment technology. The favorable decisions from the International — European Patent Office and the U.S. International Trade Commission strengthen its market position and intellectual property portfolio.

Impact: Seer, Inc. filed a complaint against Nanomics Biotechnology Company for patent infringement, seeking to protect its intellectual property in nanoparticle protein enrichment. This action aims to safeguard its market position and technology.

Impact: Seer received an unsolicited acquisition proposal from its Chair and CEO, Omid Farokhzad, M.D., which could lead to its acquisition or other strategic alternatives. The company's Board of Directors will establish a Special Committee to evaluate the proposal.

Impact: Seer is the target of a proxy contest by activist investors seeking board seats and potentially a sale. The company's board is defending its strategy and nominees.